Rice Hall James & Associates LLC出售了Alkermes的股份,但该公司的收入高于预期。 Rice Hall James & Associates LLC sold shares of Alkermes, but the company's earnings beat expectations.

Rice Hall James & Associates LLC将其在Alkermes plc(NASDAQ:ALKS)的股份减少了4.8%,在第四季度出售了21 730股。 Rice Hall James & Associates LLC reduced its holdings in Alkermes plc (NASDAQ: ALKS) by 4.8%, selling 21,730 shares in the fourth quarter. 其他机构投资者,包括Loomis Sayles & Co. L P和Frazier生命科学管理L.P. Alkermes(一家生物制药公司)增加了其职位,报告本季度每股收入为0.92美元,超过预期。 Other institutional investors increased their positions, including Loomis Sayles & Co. L P and Frazier Life Sciences Management L.P. Alkermes, a biopharmaceutical company, reported earnings per share of $0.92 for the quarter, exceeding expectations. 分析师预测“机动购买”评级为37.25美元,目标价格为37.25美元。 Analysts predict a "Moderate Buy" rating with a target price of $37.25. 机构投资者拥有公司股份的95.21%。 Institutional investors own 95.21% of the company's shares.